Evidence map›Paper›PMID 30830038›Full record

ArticleTransplantation2019

Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients.

Jordan M Chiasson, Cory E Fominaya, Mulugeta Gebregziabher, David J Taber

Abstract readMulticenter Study
In one paragraph

Article in Transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jordan M ChiassonDepartment of Pharmacy, Ralph H. Johnson VAMC, Charleston, SC.
Cory E FominayaDepartment of Pharmacy, Ralph H. Johnson VAMC, Charleston, SC.
Mulugeta GebregziabherDepartment of Pharmacy, Ralph H. Johnson VAMC, Charleston, SC.
David J TaberDepartment of Pharmacy, Ralph H. Johnson VAMC, Charleston, SC.

Funding

Impact of Cardiovascular Risk Control on Racial Disparities in Kidney TransplantK23DK099440 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TABER, DAVID J. · 2014 to 2017
$715k
Improving Transplant Medication Safety through a TEchnology and Pharmacist (ISTEP) Intervention in VeteransI01HX002130 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TABER, DAVID J. · 2018 to 2022
–
HSRD VA I01 HX002130NIDDK NIH HHS K23 DK099440
6 · The paper itself

Abstract

backgroundNonsteroidal anti-inflammatory drug (NSAID) use is recommended to be avoided in kidney transplantation, with a paucity of studies assessing their safety within this population. This study aims to use a large cohort of Veterans Affairs (VA) kidney transplantation recipients to assess the risk of acute kidney injury (AKI) with NSAID use.

methodsThis is a 10-year longitudinal cohort study of adult kidney transplant recipients retrospectively followed in the VA system from 2001 to 2010 that assessed for risk of AKI with NSAID prescriptions. NSAID prescriptions, patient characteristics, and estimated glomerular filtration rates were abstracted from the VA comprehensive electronic health record. NSAID exposure was assessed by duration, dosage, and type. AKI events were defined by ≥50% decrease in estimated glomerular filtration rate. Risk was estimated using longitudinal multivariable generalized logistic regression model.

resultsAbout 5100 patients were included with a total of 29 980 years of follow-up; 671 NSAID prescriptions in 273 (5.4%) patients (2.24 per 100 patient-y) with 472 (70%) high dose were identified. High-dose NSAID prescriptions were associated with 2.83 (95% confidence interval [CI], 1.55-5.19; P < 0.001) higher odds of AKI events within a given year; low dose was not associated with AKI (odds ratio, 1.93; 95 % CI, 0.95-6.02; P = 0.256). One 7-day NSAID course was associated with 5% higher odds of increasing AKI events, whereas chronic use (≥180 d) was associated with 3.25 (95% CI, 1.78-5.97; P < 0.001) higher odds of AKI.

conclusionsPrescriptions for NSAIDs were uncommon in this cohort but were associated with a significant increase in the risk of AKI, which was impacted by higher NSAID dose and longer NSAID durations.

Indexed as

ForecastingKidney TransplantationTransplant RecipientsAcute Kidney InjuryAnti-Inflammatory Agents, Non-SteroidalDrug PrescriptionsFemaleFollow-Up StudiesGlomerular Filtration RateHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsUnited StatesAnti-Inflammatory Agents, Non-Steroidal

Identifiers

PMID30830038
PMCPMC6717690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.